How Atezolizumab is Changing Cancer Treatment through Immunotherapy
Atezolizumab, known commercially as Tecentriq, is revolutionizing cancer treatment through its innovative immunotherapy approach. As an immune checkpoint inhibitor, it enhances the immune system’s ability to target cancer cells, offering new hope for treating various cancers, including lung and liver cancers. With FDA approvals and promising clinical outcomes laying the groundwork, a deeper exploration of […]
3 minute read